Sr. Director, Global Commercial FP&A, Business Insights & Data Science (San Diego/Hybrid)

San Diego, California, United States

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

The candidate must have a successful record of building and managing teams that collaborate with business partners to understand business needs and provide insights for informed decision-making. They should reside in the San Diego area and be able to commute to corporate offices, with relocation assistance available. A full-time commitment with 2-3 in-office days per week is expected.

Responsibilities

This role owns revenue analytics and commercial finance processes, consolidating global revenue and providing an independent view with risks and upsides. The position involves leading advanced analytic capabilities for deep revenue insights, accelerating data-driven decision-making, and managing the revenue budget, forecast, and projection processes. Responsibilities include monitoring revenue commitments, proactively sharing actions to fill shortfalls, providing business partnership to Global Sales Ops, Commercial Strategy, and Investor Relations, and delivering complex analytical solutions from predictive to prescriptive analytics. The role also entails collaborating with various teams to build business insights for strategic decision-making using structured and unstructured data, building robust predictive models, and enhancing current predictive models for global sales forecasts.

Skills

Revenue Analytics

Commercial Finance

Financial Planning & Analysis (FP&A)

Budgeting

Forecasting

Data Analysis

Business Insights

Data Science

Sales Operations

Commercial Strategy

Investor Relations

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free